Israel Englander X4 Pharmaceuticals, Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Millennium Management LLC holds 363,208 shares of XFOR stock, worth $221,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares

363,208

Previous 343,416 5.76%

Holding current value

$221,556

Previous $199,000 22.11%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.86 $10,687 - $17,021	19,792 Added 5.76%	363,208 $243,000
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.47 $49,101 - $124,445	84,657 Added 32.72%	343,416 $199,000
Q1 2024 May 15, 2024	SELL	$0.72 - $1.46 $1.01 Million - $2.05 Million	-1,405,558 Reduced 84.45%	258,759 $359,000
Q4 2023 Feb 14, 2024	SELL	$0.61 - $0.99 $2.31 Million - $3.75 Million	-3,787,293 Reduced 69.47%	1,664,317 $1.4 Million
Q2 2023 Aug 14, 2023	BUY	$0.82 - $2.49 $3.58 Million - $10.9 Million	4,371,397 Added 404.68%	5,451,610 $10.6 Million
Q1 2023 May 15, 2023	SELL	$0.8 - $1.22 $58,576 - $89,328	-73,220 Reduced 6.35%	1,080,213 $940,000
Q4 2022 Feb 14, 2023	BUY	$0.69 - $2.21 $717,923 - $2.3 Million	1,040,469 Added 921.06%	1,153,433 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $31,396 - $60,323	35,277 Added 45.41%	112,964 $193,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $287,107 - $623,154	-326,259 Reduced 80.77%	77,687 $75,000
Q1 2022 May 16, 2022	BUY	$1.48 - $2.58 $298,165 - $519,774	201,463 Added 99.5%	403,946 $707,000
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $123,281 - $363,356	-64,885 Reduced 24.27%	202,483 $464,000
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $537,434 - $765,221	-118,639 Reduced 30.73%	267,368 $1.41 Million
Q2 2021 Aug 16, 2021	BUY	$6.49 - $9.56 $2.51 Million - $3.69 Million	386,007 New	386,007 $2.51 Million
Q2 2020 Aug 14, 2020	SELL	$7.98 - $10.44 $132,037 - $172,740	-16,546 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$6.03 - $11.01 $300,263 - $548,242	-49,795 Reduced 75.06%	16,546 $165,000
Q4 2019 Feb 14, 2020	SELL	$9.93 - $14.33 $1.21 Million - $1.75 Million	-122,284 Reduced 64.83%	66,341 $710,000
Q3 2019 Nov 14, 2019	BUY	$11.06 - $15.75 $409,098 - $582,576	36,989 Added 24.39%	188,625 $2.4 Million
Q2 2019 Aug 15, 2019	BUY	$12.57 - $21.67 $1.71 Million - $2.95 Million	135,914 Added 864.48%	151,636 $2.28 Million
Q2 2019 Aug 14, 2019	BUY	$12.57 - $21.67 $197,625 - $340,695	15,722 New	15,722 $548,000

Others Institutions Holding XFOR

# of Institutions

103

Shares Held

99.9M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account